...
机译:CTDNA测定欧洲和日本高级NSCLC患者EGFR突变状况:评估研究
German Ctr Lung Res DZL Lung Clin Grosshansdorf GmbH Dept Thorac Oncol ARCN Grosshansdorf;
Jichi Med Univ Saitama Med Ctr Comprehens Med 1 Saitama Saitama Japan;
Jiao Tong Univ Shanghai Chest Hosp Dept Resp Med Shanghai Peoples R China;
Russian Canc Res Ctr Dept Clin Pharmacol &
Chemotherapy Moscow Russia;
Evangel Lung Clin Pulm Clin Berlin Germany;
Kansai Med Univ Dept Thorac Oncol Hirakata Hosp Osaka Japan;
Inst Hospitalizat &
Sci Care IRCCS Natl Canc Inst Pascale Fdn Thorac Oncol Unit Naples Italy;
Univ Turin Dept Oncol Thorac Oncol Unit Turin Italy;
Hosp Sea Dept Oncol Barcelona Spain;
Le Mans Gen Hosp Pneumol Le Mans France;
AstraZeneca Personalised Healthcare &
Biomarkers Macclesfield Cheshire England;
AstraZeneca Personalised Healthcare &
Biomarkers Macclesfield Cheshire England;
Inst Hospitalizat &
Sci Care IRCCS Natl Canc Inst Pascale Fdn Cell Biol &
Biotherapy Unit Naples;
NSCLC; EGFR mutation; ctDNA; Plasma; Real world;
机译:CTDNA测定欧洲和日本高级NSCLC患者EGFR突变状况:评估研究
机译:基于IPASS的日本患者(pts)子集中的循环游离DNA(cfDNA)进行的OP78 EGFR突变(IRESSA泛亚研究),这是一线吉非替尼(G)与卡铂/紫杉醇(C / P)的III期研究临床选择的晚期非小细胞肺癌(NSCLC)患者
机译:ddPCR和ARMS检测获得性EGFR-TKI耐药的晚期NSCLC患者ctDNA中EGFR T790M状况的比较
机译:单细胞水平晚期NSCLC患者EGFR激活突变的细胞内异质性
机译:具有微卫星不稳定性的大肠癌患者的突变谱; BRCA2和EGFR体细胞突变的频率高
机译:血浆ctDNA与基于组织/细胞学的技术在晚期NSCLC中检测EGFR突变状态的比较:ASSESS的西班牙数据子集
机译:ctDNA测定欧洲和日本晚期NSCLC患者的EGFR突变状态:ASSESS研究